We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCI
2976
DELISTED
Navigant Consulting, Inc.
NCI
-125,115
Closed -$3.5M
TYPE
2977
DELISTED
Monotype Imaging Holdings Inc.
TYPE
-127,587
Closed -$2.53M
CTWS
2978
DELISTED
Connecticut Water Service Inc
CTWS
-16,131
Closed -$1.13M
CBLK
2979
DELISTED
Carbon Black, Inc. Common Stock
CBLK
-70,886
Closed -$1.84M
VSM
2980
DELISTED
Versum Materials, Inc.
VSM
-298,021
Closed -$15.8M
BID
2981
DELISTED
Sotheby's
BID
-101,300
Closed -$5.77M
UCBH
2982
DELISTED
UCBH HOLDINGS INC
UCBH
$0 ﹤0.01%
14,002
CNB
2983
DELISTED
COLONIAL BANCGROUP INC
CNB
$0 ﹤0.01%
23,800
VIA
2984
DELISTED
Viacom Inc. Class A
VIA
-7,687
Closed -$202K
CELG
2985
DELISTED
Celgene Corp
CELG
-1,198,565
Closed -$119M
GCI
2986
DELISTED
Gannett Co., Inc
GCI
-363,373
Closed -$3.9M

Similar funds

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.